PAX5 and leukemia: Indeed, when additional mutations were separately introduced into the zebrafish orthologs of the human PAX5 and CDKN2A/B genes, which are deleted in a quarter of the E::R leukemias, the incidence increased to 15% and 7%, respectively, which is similar to what has been observed in mice [14,15,16,81].